Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1980 Nov;70(3):491–498. doi: 10.1111/j.1476-5381.1980.tb08728.x

The effects of (+)- and (-)-propranolol on 3H-transmitter efflux in guinea-pig atria and the presynaptic beta-adrenoceptor hypothesis.

S Kalsner
PMCID: PMC2044346  PMID: 6108147

Abstract

The effects of isoprenaline and of the (+)- and (-)-isomers of propranolol on the stimulation-induced overflow of 3H-transmitter was assessed in guinea-pig atria to evaluate the hypothesis of presynaptic beta-adrenoceptors. 2 Isoprenaline (1.2 x 10(-8) M) enhanced the efflux of tritium at 2 and 5 Hz with 100 pulses and did so to a similar extent at both frequencies. 3 The (-)-isomer of propranolol (1.0 x 10(-7) M) blocked the enhancing effect of isoprenaline but did not by itself modify transmitter efflux. 4 The (+)-isomer of propranolol, almost devoid of beta-adrenoceptor blocking properties, was also effective at 1.0 x 10(-7) M in blocking the enhancement of tritium efflux by isoprenaline. 5 The (-)-isomer of propranolol (1.0 x 10(-7) M) blocked almost entirely the inotropic response to isoprenaline (3 x 10(-7) M) but even 3.0 x 10(-6) M (+)-propranolol was ineffective in antagonizing the beta-adrenoceptor-mediated contractile responses to the catecholamine. 6 It is concluded that the presynaptic site of isoprenaline action does not show the requisite stereo-specificity of beta-adrenoceptors and that a 'non-specific' action of the antagonist probably accounts for its reduction of the effect of isoprenaline.

Full text

PDF
491

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler-Graschinsky E., Langer S. Z. Possible role of a beta-adrenoceptor in the regulation of noradrenaline release by nerve stimulation through a positive feed-back mechanism. Br J Pharmacol. 1975 Jan;53(1):43–50. doi: 10.1111/j.1476-5381.1975.tb07328.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Allen G. S., Henderson L. M., Chou S. N., French L. A. Cerebral arterial spasm. 1. In vitro contractile activity of vasoactive agents on canine basilar and middle cerebral arteries. J Neurosurg. 1974 Apr;40(4):433–441. doi: 10.3171/jns.1974.40.4.0433. [DOI] [PubMed] [Google Scholar]
  3. Barrett A. M., Nunn B. Adrenergic neuron blocking properties of (plus or minus)-propranolol and (plus)-propranolol. J Pharm Pharmacol. 1970 Nov;22(11):806–810. doi: 10.1111/j.2042-7158.1970.tb08443.x. [DOI] [PubMed] [Google Scholar]
  4. Bevan J. A., Garstka W., Su C., Su M. O. The bimodal basis of the contractile response of the rabbit ear artery to norepinephrine and other agonists. Eur J Pharmacol. 1973 Apr;22(1):47–53. doi: 10.1016/0014-2999(73)90182-9. [DOI] [PubMed] [Google Scholar]
  5. Brooker W. D., Calvert D. N. Blockade of catecholamine mediated release of free fatty acids from adipose tissue in vitro. Arch Int Pharmacodyn Ther. 1967 Sep;169(1):117–130. [PubMed] [Google Scholar]
  6. Celuch S. M., Dubocovich M. L., Lander S. Z. Stimulation of presynaptic beta-adrenoceptors enhances [3H]-noradrenaline release druing nerve stimulation in the perfused cat spleen. Br J Pharmacol. 1978 May;63(1):97–109. doi: 10.1111/j.1476-5381.1978.tb07779.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chan C. C., Kalsner S. An examination of the negative feedback function of presynaptic adrenoceptors in a vascular tissue. Br J Pharmacol. 1979 Nov;67(3):401–407. doi: 10.1111/j.1476-5381.1979.tb08694.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chan C. C., Kalsner S. Noradrenaline inhibition of transmitter efflux in a renal artery preparation and the presynaptic receptor theory. Can J Physiol Pharmacol. 1979 Oct;57(10):1192–1195. doi: 10.1139/y79-179. [DOI] [PubMed] [Google Scholar]
  9. Eliash S., Weinstock M. Role of adrenergic neurone blockade in the hypotensive action of propranolol. Br J Pharmacol. 1971 Oct;43(2):287–294. [PMC free article] [PubMed] [Google Scholar]
  10. Endo T., Starke K., Bangerter A., Taube H. D. Presynaptic receptor systems on the noradrenergic neurones of the rabbit pulmonary artery. Naunyn Schmiedebergs Arch Pharmacol. 1977 Feb;296(3):229–247. doi: 10.1007/BF00498689. [DOI] [PubMed] [Google Scholar]
  11. FURCHGOTT R. F. Dibenamine blockade in strips of rabbit aorta and its use in differentiating receptors. J Pharmacol Exp Ther. 1954 Jul;111(3):265–284. [PubMed] [Google Scholar]
  12. Farnebo L. O., Hamberger B. Influence of alpha- and beta-adrenoceptors on the release of noradrenaline from field stimulated atria and cerebral cortex slices. J Pharm Pharmacol. 1974 Aug;26(8):644–646. doi: 10.1111/j.2042-7158.1974.tb10681.x. [DOI] [PubMed] [Google Scholar]
  13. Furchgott R. F., Garcia P. S., Wakade A. R., Cervoni P. Interactions of bretylium and other drugs on guinea-pig atria: evidence for inhibition of neuronal monoamine oxidase by bretylium. J Pharmacol Exp Ther. 1971 Nov;179(2):171–185. [PubMed] [Google Scholar]
  14. Furchgott R. F., Sanchez Garcia P. Effects of inhibition of monoamine oxidase on the actions and interactions of norepinephrine, tyramine and other drugs on guinea-pig left atrium. J Pharmacol Exp Ther. 1968 Sep;163(1):98–122. [PubMed] [Google Scholar]
  15. Guimarães S., Osswald W. Adrenergic receptors in the veins of the dog. Eur J Pharmacol. 1969 Jan;5(2):133–140. doi: 10.1016/0014-2999(69)90021-1. [DOI] [PubMed] [Google Scholar]
  16. Guimarães S. The slopes of cumulative and non-cumulative dose--response curves for noradrenaline and isoprenaline. Eur J Pharmacol. 1972 Jan;17(1):44–49. doi: 10.1016/0014-2999(72)90267-1. [DOI] [PubMed] [Google Scholar]
  17. Hedges A., Turner P. Beta-receptors in human isolated smooth muscle. Br J Pharmacol. 1969 Oct;37(2):547P–548P. [PMC free article] [PubMed] [Google Scholar]
  18. Hermansen K. Anti-arrhythmic, local anaesthetic, and adrenergic blocking activity of some beta-receptor antagonists. Br J Pharmacol. 1969 Mar;35(3):476–486. doi: 10.1111/j.1476-5381.1969.tb08289.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ignarro L. J., Titus E. The presence of antagonistically acting alpha and beta adrenergic receptors in the mouse spleen. J Pharmacol Exp Ther. 1968 Mar;160(1):72–80. [PubMed] [Google Scholar]
  20. Johansson B., Johansson S. R., Ljung B., Stage L. A receptor kinetic model of a vascular neuroeffector. J Pharmacol Exp Ther. 1972 Mar;180(3):636–646. [PubMed] [Google Scholar]
  21. Kalsner S. Adrenergic presynaptic receptors: examination of a hypothesis in guinea pig vas deferens. Can J Physiol Pharmacol. 1979 Jul;57(7):717–724. doi: 10.1139/y79-108. [DOI] [PubMed] [Google Scholar]
  22. Kalsner S., Chan C. C. Adrenergic antagonists and the presynaptic receptor hypothesis in vascular tissue. J Pharmacol Exp Ther. 1979 Nov;211(2):257–264. [PubMed] [Google Scholar]
  23. Kalsner S., Frew R. D., Smith G. M. Mechanism of methylxanthine sensitization of norepinephrine responses in a coronaryartery. Am J Physiol. 1975 Jun;228(6):1702–1707. doi: 10.1152/ajplegacy.1975.228.6.1702. [DOI] [PubMed] [Google Scholar]
  24. Kalsner S. Limitations of presynaptic adrenoceptor theory: the characteristics of the effects of noradrenaline and phenoxybenzamine on stimulation-induced efflux of [3H]noradrenaline in vas deferens. J Pharmacol Exp Ther. 1980 Feb;212(2):232–239. [PubMed] [Google Scholar]
  25. Kalsner S. Mechanisms of inactivation of noradrenaline in the iris sphincter, tracheal muscle and facial artery of cattle: implications for beta-adrenoceptor-mediated responses. Br J Pharmacol. 1978 Dec;64(4):545–552. doi: 10.1111/j.1476-5381.1978.tb17316.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kalsner S., Nickerson M., Boyd G. N. Selective blockade of potassium-induced contractions of aortic strips by beta-diethylaminoethyl-diphenylpropylacetate (SKF 525A). J Pharmacol Exp Ther. 1970 Sep;174(3):500–508. [PubMed] [Google Scholar]
  27. Kalsner S. Single pulse stimulation of guinea-pig vas deferens and the presynaptic receptor hypothesis. Br J Pharmacol. 1979 Jun;66(2):343–349. doi: 10.1111/j.1476-5381.1979.tb13686.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Langer S. Z. Sixth gaddum memorial lecture, National Institute for Medical Research, Mill Hill, January 1977. Presynaptic receptors and their role in the regulation of transmitter release. Br J Pharmacol. 1977 Aug;60(4):481–497. doi: 10.1111/j.1476-5381.1977.tb07526.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Langer S. Z. The role of alpha- and beta-presynaptic receptors in the regulation of noradrenaline release elicited by nerve stimulation. Clin Sci Mol Med Suppl. 1976 Dec;3:423s–426s. doi: 10.1042/cs051423s. [DOI] [PubMed] [Google Scholar]
  30. Langer S. Z., Trendelenburg U. The effect of a saturable uptake mechanism on the slopes of dose-response curves for sympathomimetic amines and on the shifts of dose-response curves produced by a competitive antagonist. J Pharmacol Exp Ther. 1969 May;167(1):117–142. [PubMed] [Google Scholar]
  31. Levy B., Wilkenfeld B. E. The potentiation of rat uterine inhibitory responses to noradrenaline by theophylline and nitroglycerine. Br J Pharmacol. 1968 Nov;34(3):604–612. doi: 10.1111/j.1476-5381.1968.tb08489.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Mylecharane E. J., Raper C. Further studies on the adrenergic neuron blocking activity of some -adrenoceptor antagonists and guanethidine. J Pharm Pharmacol. 1973 Mar;25(3):213–220. doi: 10.1111/j.2042-7158.1973.tb10627.x. [DOI] [PubMed] [Google Scholar]
  33. Persson H., Johnson B. Adrergic receptors in the guinea pig trachea and lung. Acta Pharmacol Toxicol (Copenh) 1970;28(1):49–56. doi: 10.1111/j.1600-0773.1969.tb00528.x. [DOI] [PubMed] [Google Scholar]
  34. Reiffenstein R. J. Effects of cocaine on the rate of contraction to noradrenaline in the cat spleen strip: mode of action of cocaine. Br J Pharmacol Chemother. 1968 Mar;32(3):591–597. doi: 10.1111/j.1476-5381.1968.tb00459.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Starke K. Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol. 1977;77:1–124. doi: 10.1007/BFb0050157. [DOI] [PubMed] [Google Scholar]
  36. Stjärne L., Brundin J. Beta2-adrenoceptors facilitating noradrenaline secretion from human vasoconstrictor nerves. Acta Physiol Scand. 1976 Mar;97(1):88–93. doi: 10.1111/j.1748-1716.1976.tb10238.x. [DOI] [PubMed] [Google Scholar]
  37. Stjärne L. Selectivity for catecholamines of presynaptic alpha-receptors involved in feedback control of sympathetic neurotransmitter secretion in guinea-pig vas deferens. Naunyn Schmiedebergs Arch Pharmacol. 1975;288(2-3):296–303. doi: 10.1007/BF00500534. [DOI] [PubMed] [Google Scholar]
  38. VAN ROSSUMJ DIFFERENT TYPES OF SYMPATHOMIMETIC ALPHA-RECEPTORS. J Pharm Pharmacol. 1965 Apr;17:202–216. doi: 10.1111/j.2042-7158.1965.tb07646.x. [DOI] [PubMed] [Google Scholar]
  39. Varma D. R., McCullough H. N. Dissociation of the supersensitivity to norepinephrine caused by cocaine from inhibition of H3-norepinephrine uptake in cold-stored smooth muscle. J Pharmacol Exp Ther. 1969 Mar;166(1):26–34. [PubMed] [Google Scholar]
  40. Westfall D. P., Fleming W. W. The sensitivity of the guinea-pig pacemaker to norepinephrine and calcium after pretreatment with reserpine. J Pharmacol Exp Ther. 1968 Dec;164(2):259–269. [PubMed] [Google Scholar]
  41. Westfall T. C. Local regulation of adrenergic neurotransmission. Physiol Rev. 1977 Oct;57(4):659–728. doi: 10.1152/physrev.1977.57.4.659. [DOI] [PubMed] [Google Scholar]
  42. Williams E. M. Mode of action of beta receptor antagonists on cardiac muscle. Am J Cardiol. 1966 Sep;18(3):399–405. doi: 10.1016/0002-9149(66)90062-2. [DOI] [PubMed] [Google Scholar]
  43. van Zwieten P. A. Decrease in ionic permeability of the cell membrane in guinea-pig atrial tissue by treatment with antifibrillatory agents and hexobarbitone, determined by means of 86Rb. Br J Pharmacol. 1969 Jan;35(1):103–111. doi: 10.1111/j.1476-5381.1969.tb07970.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES